Recombinant Human Ephrin A1 protein (ab112282)

Overview

Description

  • NatureRecombinant
  • SourceWheat germ
  • Amino Acid Sequence
    • AccessionP20827
    • SpeciesHuman
    • Molecular weight49 kDa
    • Amino acids1 to 205
    • TagsGST tag N-Terminus

Associated products

Specifications

Our Abpromise guarantee covers the use of ab112282 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Biological activityuseful for Antibody Production and Protein Array
  • Applications

    Western blot

    Peptide Array

    ELISA

    SDS-PAGE

  • FormLiquid
  • Additional notesBest use within three months from the date of receipt of this protein.useful for Antibody Production and Protein Array
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    pH: 8.00
    Constituents: 0.79% Tris HCl, 0.31% Glutathione
    Note: Reduced glutathione

General Info

  • Alternative names
    • B61
    • ECKLG
    • EFL 1
    • EFL1
    • EFNA 1
    • Efna1
    • EFNA1_HUMAN
    • EPH related receptor tyrosine kinase ligand 1
    • EPH-related receptor tyrosine kinase ligand 1
    • Ephrin-A1
    • Ephrin-A1, secreted form
    • EphrinA1
    • EPLG 1
    • EPLG1
    • Immediate early response protein B61
    • LERK 1
    • LERK-1
    • LERK1
    • Ligand of eph related kinase 1
    • OTTHUMP00000033242
    • OTTHUMP00000033271
    • secreted form
    • TNF alpha-induced protein 4
    • TNFAIP 4
    • TNFAIP4
    • Tumor necrosis factor alpha induced protein 4
    • Tumor necrosis factor alpha-induced protein 4
    see all
  • FunctionPlays an important role in angiogenesis and tumor neovascularization. The recruitement of VAV2, VAV3 and PI3-kinase p85 subunit by phosphorylated EPHA2 is critical for EFNA1-induced RAC1 GTPase activation and vascular endothelial cell migration and assembly (By similarity). Exerts anti-oncogenic effects in tumor cells through activation and down-regulation of EPHA2. Activates EPHA2 by inducing tyrosine phosphorylation which leads to its internalization and degradation. Acts as a negative regulator in the tumorigenesis of gliomas by down-regulating EPHA2 and FAK. Can evoke collapse of embryonic neuronal growth cones.
  • Tissue specificityBrain. Down-regulated in primary glioma tissues compared to the normal tissues. The soluble monomeric form is expressed in the glioblastoma multiforme (GBM) and breast cancer cells (at protein level).
  • Sequence similaritiesBelongs to the ephrin family.
  • Post-translational
    modifications
    Undergo proteolysis by a metalloprotease to give rise to a soluble monomeric form.
  • Cellular localizationSecreted and Cell membrane.
  • Information by UniProt

Recombinant Human Ephrin A1 protein images

  • 12.5% SDS-PAGE Stained with Coomassie Blue with recombinant protein.
  • All lanes : Anti-Ephrin A1 antibody (ab65072) at 1 µg/ml

    Lane 1 : Recombinant Human Ephrin A1 protein (ab112282) at 0.1 µg
    Lane 2 : Recombinant Human Ephrin A1 protein (ab112282) at 0.01 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
    Developed using the ECL technique

    Performed under reducing conditions.

    Exposure time : 150 seconds

References for Recombinant Human Ephrin A1 protein (ab112282)

ab112282 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab112282.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"